Health Care: Drugs

Novavax Inc (NVAX: NASDAQ)

$4.66 n/a | n/a%
02/10/16 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 4.66
52 Week High 15.01
52 Week Low 4.08
Avg. Daily Vol. (Mil) 7.05
Beta (3 year) 1.82
Share Related Items
Mkt Cap (Mil) 1,257.54
Shares Out (Mil) 269.86
Float (Mil) 230.08
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 11.80
Current Ratio 12.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 33.88
Price/Book 3.43
Price/Cash Flow -12.30
Per Share Data
Earnings -0.44
Sales 0.14
Book Value 1.36
Cash Flow -0.38
Business Summary
Novavax Inc is a clinical-stage vaccine company engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
General Information
20 Firstfield Road
Garthersburg, MD 20878
Industry : Drugs
Sector: Health Care
Employees: 308
CEO: Stanley C. Erck
Short Interest
Current Month (Mil) 50.74
Previous Month (Mil) 39.52
Short Interest Ratio (Days) 6.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -27.10
Return on Investments -29.90
Gross Margin 90.10
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NVAX

Latest NVAX Headlines from TheStreet

More Financial News for NVAX

Press Releases for NVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter